Literature DB >> 27020400

Inflammatory response in chronic degenerative endometritis mares treated with platelet-rich plasma.

Maria Fernanda S Reghini1, Carlos Ramires Neto1, Lorenzo G Segabinazzi1, Maria Manoela B Castro Chaves1, Camila de Paula F Dell'Aqua1, Maria Clara C Bussiere2, José Antonio Dell'Aqua1, Frederico O Papa1, Marco Antonio Alvarenga3.   

Abstract

Degenerative changes of the endometrium are directly related to age and fertility in mares. Chronic degenerative endometritis (CDE) is correlated with uterine fluid retention and reduced ability to clear uterine inflammation. Recent research in the areas of equine surgery and sports medicine has shown that platelet-rich plasma (PRP) treatment acts as an immunomodulator of the inflammatory response. Therefore, the aim of this study was to determine if the uterine infusion of PRP could modulate the local inflammatory response and modify the intrauterine NO concentrations after artificial insemination (AI) in both normal mares and those with CDE. Thirteen mares with endometrium classified as grade III on the histology (mares with CDE) and eight mares with endometrial histological classification I or II-a normal mares were selected to investigate the effect of PRP therapy. The mares were inseminated with fresh semen in two consecutive cycles in a crossover study design. Thereby, each mare served as its own control and the treatment was performed with intrauterine PRP infusion four hours after AI. The percentage of neutrophils in uterine cytology (CIT, %), uterine fluid accumulation observed on ultrasonography (FLU, mm) and nitric oxide concentration of uterine fluid (NO, μM) were analyzed before and 24 hours after AI. The results reported that mares with CDE (CIT, 68.3 ± 3.27, FLU, 10.7 ± 1.61) have a higher (P < 0.05) intrauterine inflammatory response after AI than normal mares (CIT, 24.4 ± 3.56, FLU, 0), but NO concentrations did not differ (P > 0.05) between categories of mares. In treated cycles with PRP, the intrauterine inflammatory response decrease (P < 0.05) in CDE mares (CDE: CIT, 31.4 ± 6.48, FLU, 5.5 ± 1.28; normal mares: CIT, 13.5 ± 4.31, FLU, 0) when compared with nontreated cycle (CDE: CIT, 68.3 ± 3.27, FLU, 10.7 ± 1.61; NM: CIT, 24.4 ± 3.56, FLU, 0), but did not modify NO concentrations in uterine fluid. Thus, we can conclude that PRP was effective in modulating the exacerbated uterine inflammatory response to semen in mares with CDE but did not reduce NO concentrations in intrauterine fluid.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic degenerative endometritis; Endometriosis; Mare; Nitric oxide; Platelet-rich plasma

Mesh:

Year:  2016        PMID: 27020400     DOI: 10.1016/j.theriogenology.2016.01.029

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  15 in total

1.  In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration.

Authors:  Lusine Aghajanova; Sahar Houshdaran; Shaina Balayan; Evelina Manvelyan; Juan C Irwin; Heather G Huddleston; Linda C Giudice
Journal:  J Assist Reprod Genet       Date:  2018-02-05       Impact factor: 3.412

2.  Platelet-rich plasma or blood-derived products to improve endometrial receptivity?

Authors:  Adriana Bos-Mikich; Marcelo O Ferreira; Ricardo de Oliveira; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2019-01-04       Impact factor: 3.412

3.  Platelet-rich plasma therapy and reproductive medicine.

Authors:  Adriana Bos-Mikich; Ricardo de Oliveira; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2018-03-21       Impact factor: 3.412

Review 4.  Use of Intra-uterine Injection of Platelet-rich Plasma (PRP) for Endometrial Receptivity and Thickness: a Literature Review of the Mechanisms of Action.

Authors:  Marco Mouanness; Shelena Ali-Bynom; Janelle Jackman; Serin Seckin; Zaher Merhi
Journal:  Reprod Sci       Date:  2021-04-22       Impact factor: 3.060

5.  Intrauterine Blood Plasma Platelet-Therapy Mitigates Persistent Breeding-Induced Endometritis, Reduces Uterine Infections, and Improves Embryo Recovery in Mares.

Authors:  Lorenzo G T M Segabinazzi; Igor F Canisso; Giorgia Podico; Lais L Cunha; Guilherme Novello; Michael F Rosser; Shavahn C Loux; Fabio S Lima; Marco A Alvarenga
Journal:  Antibiotics (Basel)       Date:  2021-04-23

Review 6.  Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency.

Authors:  Mara Ulin; Esra Cetin; Elie Hobeika; Rishi Man Chugh; Hang-Soo Park; Sahar Esfandyari; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2021-05-06       Impact factor: 3.060

7.  Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study.

Authors:  Leila Nazari; Saghar Salehpour; Sedighe Hoseini; Shahrzad Zadehmodarres; Ladan Ajori
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-10

8.  Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis.

Authors:  Shichao Tong; Jimin Yin; Ji Liu
Journal:  Exp Ther Med       Date:  2017-12-18       Impact factor: 2.447

9.  A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment.

Authors:  Konstantinos Pantos; Mara Simopoulou; Agni Pantou; Anna Rapani; Petroula Tsioulou; Nikolaos Nitsos; Stephen Syrkos; Athanasios Pappas; Michael Koutsilieris; Konstantinos Sfakianoudis
Journal:  Cell Transplant       Date:  2019-07-04       Impact factor: 4.064

10.  Three Manual Noncommercial Methods to Prepare Equine Platelet-Rich Plasma.

Authors:  Lorenzo G T M Segabinazzi; Giorgia Podico; Michael F Rosser; Som G Nanjappa; Marco A Alvarenga; Igor F Canisso
Journal:  Animals (Basel)       Date:  2021-05-21       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.